Johnson & Johnson Acquires Ambrx Biopharma for $2B

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

Related Keywords

Ambrx Biopharma ,Yusria Elsayed ,Johnson Johson ,Margaret Yu ,Johnson ,Pfizer ,Increase Revenues ,Buyout Deal ,New Brunswick ,New Jersey Headquartered ,Johnson Innovative Medicine ,Real Time Economy News ,Orex News ,Igital Currency News ,Conomy Research ,Conomy Commentaries ,